Applied Materials Aktie
173,87USD | -7,29USD | -4,02% |
WKN: 865177 / ISIN: US0382221051
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,46 |
The Vanguard Group, Inc. | 8,99 |
Vanguard Group, Inc. (Subfiler) | 8,83 |
State Street Corp. | 4,71 |
BlackRock Fund Advisors | 3,64 |
Vanguard Total Stock Market ETF | 3,16 |
Vanguard 500 Index Fund | 2,66 |
Capital Research & Management Co. (International Investors) | 2,53 |
Geode Capital Management LLC | 2,40 |
BlackRock Institutional Trust Co. NA | 2,22 |
Invesco QQQ Trust | 1,94 |
Capital Research & Management Co. (World Investors) | 1,92 |
Norges Bank (13F) | 1,30 |
Fidelity Management & Research Co. LLC | 1,24 |
Fidelity 500 Index Fund | 1,23 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 24 000 | 27 000 | 33 000 | 34 000 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,72 | 0,85 | 0,78 | 0,78 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 13 369 | 16 107 | 15 925 | 19 147 | 21 220 |
Summe Anlagevermögen | 8 984 | 9 718 | 10 801 | 11 582 | 13 189 |
Summe Aktiva | 22 353 | 25 825 | 26 726 | 30 729 | 34 409 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 11 775 | 13 578 | 14 532 | 14 380 | 15 408 |
Summe Eigenkapital | 10 578 | 12 247 | 12 194 | 16 349 | 19 001 |
Summe Passiva | 22 353 | 25 825 | 26 726 | 30 729 | 34 409 |
Adresse
3050 Bowers Avenue, 95054-3299 Santa Clara | |
Telefon | +1 (408) 727-5555 |
Internet | http://www.appliedmaterials.com |
Management
Aart J. de Geus
Independent Director |
Adam Sanders
Chief Accounting Officer & Corporate Controller |
Alexander A. Karsner
Independent Director |
Brice A. Hill
Chief Financial Officer & Senior Vice President |
Charles W. Read
Vice President-Business Units |
Chris Librie
Senior Director-Environmental, Social & Governance |
Eric Chen
Independent Director |
Gary E. Dickerson
President, Chief Executive Officer & Director |
James C. Morgan
Chairman-Emeritus |
Judy Bruner
Independent Director |
Kang Sun
Managing Director-New Business Development |
Kevin P. March
Independent Director |
Michael B. Thompson
Director-Pharma Marketing |
Michael Sullivan
VP-Investor Relations & Marketing Communications |
Omkaram Nalamasu
Chief Technology Officer & Senior Vice President |
Prabu G. Raja
SVP-Semiconductor Products Group |
Raman Achutharama
Group Vice President-Joint Operations |
Rani Borkar
Independent Director |
Robert J. Halliday
Vice President |
Scott A. McGregor
Independent Director |
Siobhan Kenney
Director-Global Community Affairs |
Susan J. Schmitt Winchester
Chief Human Resources Officer & Senior VP |
Teri A. Little
Secretary, Chief Legal Officer & Senior VP |
Thomas C. Baker
Vice President, CFO-New Markets & Service Group |
Thomas J. Iannotti
Independent Chairman |
Timothy M. Deane
Group Vice President-Applied Global Services |
Tristan Holtam
Chief of Staff & Group Vice President |
Yvonne McGill
Independent Director |